naproxen sodium

Generic: naproxen sodium

Labeler: dolgencorp, inc. (dollar general & rexall)
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name naproxen sodium
Generic Name naproxen sodium
Labeler dolgencorp, inc. (dollar general & rexall)
Dosage Form CAPSULE, LIQUID FILLED
Routes
ORAL
Active Ingredients

naproxen sodium 220 mg/1

Manufacturer
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)

Identifiers & Regulatory

Product NDC 55910-748
Product ID 55910-748_307c61c9-238c-48eb-ab5c-97e2c1dd78d4
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA208363
Listing Expiration 2026-12-31
Marketing Start 2018-04-01

Pharmacologic Class

Classes
anti-inflammatory agents non-steroidal [cs] cyclooxygenase inhibitors [moa] nonsteroidal anti-inflammatory drug [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55910748
Hyphenated Format 55910-748

Supplemental Identifiers

RxCUI
1112231
UPC
0359726175203
UNII
9TN87S3A3C

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name naproxen sodium (source: ndc)
Generic Name naproxen sodium (source: ndc)
Application Number ANDA208363 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 220 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 BOX (55910-748-20) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC
  • 1 BOTTLE, PLASTIC in 1 BOX (55910-748-40) / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC
source: ndc

Packages (2)

Ingredients (1)

naproxen sodium (220 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "307c61c9-238c-48eb-ab5c-97e2c1dd78d4", "openfda": {"upc": ["0359726175203"], "unii": ["9TN87S3A3C"], "rxcui": ["1112231"], "spl_set_id": ["de03311d-fb58-43f5-a110-aac9a39c9132"], "manufacturer_name": ["Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (55910-748-20)  / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC", "package_ndc": "55910-748-20", "marketing_start_date": "20180401"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (55910-748-40)  / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC", "package_ndc": "55910-748-40", "marketing_start_date": "20180401"}], "brand_name": "Naproxen Sodium", "product_id": "55910-748_307c61c9-238c-48eb-ab5c-97e2c1dd78d4", "dosage_form": "CAPSULE, LIQUID FILLED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "55910-748", "generic_name": "Naproxen Sodium", "labeler_name": "Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Naproxen Sodium", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA208363", "marketing_category": "ANDA", "marketing_start_date": "20180401", "listing_expiration_date": "20261231"}